PMC:7601109 / 3008-3249 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T84139","span":{"begin":23,"end":29},"obj":"Body_part"},{"id":"T62520","span":{"begin":82,"end":86},"obj":"Body_part"}],"attributes":[{"id":"A95712","pred":"fma_id","subj":"T84139","obj":"http://purl.org/sig/ont/fma/fma32558"},{"id":"A77297","pred":"fma_id","subj":"T62520","obj":"http://purl.org/sig/ont/fma/fma256135"}],"text":"f sarcopenia, skeletal muscle loss/weakness is also on the rise [1]. Loss of lean body mass is a direct effect of the inflammatory and oxidative conditions that develop with aging [1,2]—described as inflammaging. Both inflammatory mediators "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":2,"end":12},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0006516"}],"text":"f sarcopenia, skeletal muscle loss/weakness is also on the rise [1]. Loss of lean body mass is a direct effect of the inflammatory and oxidative conditions that develop with aging [1,2]—described as inflammaging. Both inflammatory mediators "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T35774","span":{"begin":14,"end":29},"obj":"http://purl.obolibrary.org/obo/UBERON_0001134"},{"id":"T4366","span":{"begin":14,"end":29},"obj":"http://purl.obolibrary.org/obo/UBERON_0014892"},{"id":"T73667","span":{"begin":14,"end":29},"obj":"http://www.ebi.ac.uk/efo/EFO_0000888"},{"id":"T64354","span":{"begin":95,"end":96},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"f sarcopenia, skeletal muscle loss/weakness is also on the rise [1]. Loss of lean body mass is a direct effect of the inflammatory and oxidative conditions that develop with aging [1,2]—described as inflammaging. Both inflammatory mediators "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T56212","span":{"begin":174,"end":179},"obj":"http://purl.obolibrary.org/obo/GO_0007568"}],"text":"f sarcopenia, skeletal muscle loss/weakness is also on the rise [1]. Loss of lean body mass is a direct effect of the inflammatory and oxidative conditions that develop with aging [1,2]—described as inflammaging. Both inflammatory mediators "}

{"project":"LitCovid-sentences","denotations":[{"id":"T22","span":{"begin":69,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"f sarcopenia, skeletal muscle loss/weakness is also on the rise [1]. Loss of lean body mass is a direct effect of the inflammatory and oxidative conditions that develop with aging [1,2]—described as inflammaging. Both inflammatory mediators "}

{"project":"LitCovid-PubTator","denotations":[{"id":"60","span":{"begin":2,"end":12},"obj":"Disease"},{"id":"61","span":{"begin":23,"end":43},"obj":"Disease"}],"attributes":[{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"MESH:D055948"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D018908"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"f sarcopenia, skeletal muscle loss/weakness is also on the rise [1]. Loss of lean body mass is a direct effect of the inflammatory and oxidative conditions that develop with aging [1,2]—described as inflammaging. Both inflammatory mediators "}